Investigational New Drugs

译名:新药研究

INVESTIGATIONAL NEW DRUGS

SCIEJCR Q2中科院3区

3-5

2026

影响因子区间

81天

平台估算

投稿周期

50%

2025

中国作者发文占比

费用说明

收费

期刊简介:The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.

【译文】新抗癌药物的开发是癌症研究中最快速变化的方面之一。调查新药为快速传播关于新抗癌药物的信息提供了一个论坛。发表的文章对药物化学家、毒理学家、药剂师、药理学家、生物统计学家和临床肿瘤学家都感兴趣。调查新药为开发抗癌药物的整个科学界提供了最快的新发现和结果发布。

出版社
Springer Science+Business Media
语言
English
学科
医学
ISSN
0167-6997
eISSN
1573-0646
出版频率
季刊
创刊年份
1983
投稿网址
https://www.editorialmanager.com/drug
最近更新
2026-04-02 18:16:40
Investigational New Drugs

指标当前值近三年趋势
JCR分区Q2
暂无
中科院分区3区
暂无
影响因子区间3-5
暂无